Priscilla Frenette1, Linda Dodds2, B Anthony Armson3, Krista Jangaard4. 1. Faculty of Medicine, Dalhousie University, Halifax NS. 2. Perinatal Epidemiology Research Unit, Dalhousie University, Halifax NS; Department of Obstetrics and Gynaecology, Dalhousie University, Halifax NS; Department of Pediatrics, Dalhousie University, Halifax NS. 3. Department of Obstetrics and Gynaecology, Dalhousie University, Halifax NS. 4. Department of Pediatrics, Dalhousie University, Halifax NS.
Abstract
OBJECTIVES: To compare risks of infection and prematurity-related outcomes according to latency periods among women with preterm prelabour rupture of membranes (PPROM). METHODS: Women with PPROM occurring between 24+0 and 36+6 weeks of gestation were identified from a provincial population-based perinatal database in Nova Scotia. The primary outcomes included composite variables for serious maternal and neonatal infectious morbidity and neonatal prematurity-related morbidity. Logistic regression was used to quantify the relationship between latency period (< 24 hours, 24 hours to < 48 hours, 48 hours to < 7 days, and ≥ 7 days) and maternal and neonatal outcomes. Separate analyses were conducted for gestational age groups 24+0 to 33+6 weeks and 34+0 to 36+6 weeks. RESULTS: There were 4329 women included in the cohort. The composite variables representing serious maternal or neonatal infectious morbidity were not significantly associated with latency for either gestational age group. For PPROM occurring at gestational ages of 24+0 to 33+6 weeks, the odds of neonatal prematurity-related morbidity were significantly decreased at the latency periods of 48 hours or more compared with < 24 hours latency. For PPROM at 34+0 to 36+6 weeks of gestation, the odds of prematurity-related morbidity at 48 hours to < 7 days latency was decreased compared with latencies < 24 hours (OR 0.4; 95% CI 0.2 to 0.8). CONCLUSION: Postponing delivery following PPROM may contribute to less prematurity-related morbidity, even close to term, without putting mother or neonate at substantial risk for serious infectious morbidity. Generalization of these findings to other obstetric populations should be informed by the underlying risk of infection.
OBJECTIVES: To compare risks of infection and prematurity-related outcomes according to latency periods among women with preterm prelabour rupture of membranes (PPROM). METHODS:Women with PPROM occurring between 24+0 and 36+6 weeks of gestation were identified from a provincial population-based perinatal database in Nova Scotia. The primary outcomes included composite variables for serious maternal and neonatal infectious morbidity and neonatal prematurity-related morbidity. Logistic regression was used to quantify the relationship between latency period (< 24 hours, 24 hours to < 48 hours, 48 hours to < 7 days, and ≥ 7 days) and maternal and neonatal outcomes. Separate analyses were conducted for gestational age groups 24+0 to 33+6 weeks and 34+0 to 36+6 weeks. RESULTS: There were 4329 women included in the cohort. The composite variables representing serious maternal or neonatal infectious morbidity were not significantly associated with latency for either gestational age group. For PPROM occurring at gestational ages of 24+0 to 33+6 weeks, the odds of neonatal prematurity-related morbidity were significantly decreased at the latency periods of 48 hours or more compared with < 24 hours latency. For PPROM at 34+0 to 36+6 weeks of gestation, the odds of prematurity-related morbidity at 48 hours to < 7 days latency was decreased compared with latencies < 24 hours (OR 0.4; 95% CI 0.2 to 0.8). CONCLUSION: Postponing delivery following PPROM may contribute to less prematurity-related morbidity, even close to term, without putting mother or neonate at substantial risk for serious infectious morbidity. Generalization of these findings to other obstetric populations should be informed by the underlying risk of infection.
Entities:
Keywords:
infection; morbidity; neonatal prematurity; premature rupture of fetal membranes
Authors: Marian Kacerovsky; Roberto Romero; Lenka Pliskova; Radka Bolehovska; Helena Hornychova; Adela Matejkova; Hana Vosmikova; Ctirad Andrys; Martina Kolackova; Piotr Laudański; Vera Pelantova; Bo Jacobsson; Ivana Musilova Journal: J Matern Fetal Neonatal Med Date: 2019-07-15
Authors: Ivana Musilova; Radka Kutová; Lenka Pliskova; Martin Stepan; Ramkumar Menon; Bo Jacobsson; Marian Kacerovsky Journal: PLoS One Date: 2015-07-24 Impact factor: 3.240
Authors: Teenus Paramel Jayaprakash; Emily C Wagner; Julie van Schalkwyk; Arianne Y K Albert; Janet E Hill; Deborah M Money Journal: PLoS One Date: 2016-11-18 Impact factor: 3.240
Authors: Shuwei Zhou; Lingwei Mei; Wei Zhou; Yajun Yang; Xiaoyan Zhang; Xiaoling Mu; Quan Quan; Lan Wang Journal: Front Med (Lausanne) Date: 2022-03-04